FDA
Conferences
- AACR
- ASBRS
- ASCO
- SABCS
- ASH
- ESMO
- MOASC
- Upcoming Oncology Conferences
Cancers
About
Contact
Advertise
- Advertising and Services – Media Kit 2025 – OncologyTube.com
- Oncology Press Release Distribution

Advertisement

X (Twitter) LinkedIn Facebook

X (Twitter) LinkedIn Facebook YouTube

FDA
Conferences
- AACR
- ASBRS
- ASCO
- SABCS
- ASH
- ESMO
- MOASC
- Upcoming Oncology Conferences
Cancers
About
Contact
Advertise
- Advertising and Services – Media Kit 2025 – OncologyTube.com
- Oncology Press Release Distribution

[the_ad id="32629"]

Home » ALPN-101 #ASH19 @AlpineImmuneSci

Immunotherapy

ALPN-101 #ASH19 @AlpineImmuneSci

By EditorDecember 18, 2019No Comments1 Min Read

Twitter LinkedIn Facebook Email

Share

Twitter LinkedIn Facebook Email

Jan Hillson, MD of @AlpineImmuneSci disucsses ALPN-101.

Advertisement

Follow on X (Twitter) Follow on LinkedIn Follow on Facebook Follow on Google News

Share. Twitter LinkedIn Facebook Email

Related Posts

2025 Breast Cancer Immunotherapy Trial Updates

Breast Cancer 3 Mins Read

Pancreatic Cancer Trial: 28.9 months OS in AMPLIFY-201

Immunotherapy 2 Mins Read

2025 Melanoma Immunotherapy: Exercise & Microbiome

Immunotherapy 3 Mins Read

Recent Posts

ESMO 2025 Top 10 Breast Cancer Abstracts: 10 Positive Breakthroughs
TCR-T Therapy: 49% Risk Cut & 39% Response
ESMO 2025 Top 10 Genitourinary Cancer Must-See Abstracts: 78% rPFS Boost Unveiled
Immune Checkpoint Inhibitors Myocarditis: 1% Risk, 50% Fatal – UCSF Insights
TIL Therapy Breakthroughs for Oncologists and Oncology Professionals

Connect With Us on Social

Facebook
Twitter
LinkedIn
YouTube

X (Twitter) LinkedIn Facebook YouTube

FDA
Conferences
- AACR
- ASBRS
- ASCO
- SABCS
- ASH
- ESMO
- MOASC
- Upcoming Oncology Conferences
Cancers
About
Contact
Advertise
- Advertising and Services – Media Kit 2025 – OncologyTube.com
- Oncology Press Release Distribution

© 2025 Copyright Protected Medicus Networks, Inc. Privacy Policy

Type above and press Enter to search. Press Esc to cancel.